Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 99 filings·Updated 28 Sept 2026
Showing 10 of 99 filings.
28 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Religare Enterprises Limited — Trading Window closed from October 01, 2026 till 48 hours after declaration of Un-Audited Financial Results for the quarter ended September 30, 2026.

Religare Enterprises Limited — Trading Window closed from October 01, 2026 till 48 hours after declaration of Un-Audited Financial Results for the quarter ended September 30, 2026.

Filed 18:01View Source
25 Sept 20262 filings
Company UpdateChange in Management

Religare Enterprises approves Arjun Lamba re-designation as MD, effective Aug 12, 2026

MD re-designation

  • Arjun Lamba re-designated as Managing Director, not liable to retire by rotation, effective Aug 12, 2026.
  • Approved by Members at the 42nd AGM on Sep 24, 2026.
  • Not debarred from holding director office by SEBI order.
Filed 17:04View Source
AGM/EGMAGM

Religare Enterprises' 42nd AGM approves financials, director re-appointment, and MD designation.

AGM Details

  • Date, time and mode: 24 Sep 2026, 3:00 PM, via video conferencing.

Key Resolutions

  • Adoption of standalone financial statements (ordinary) – passed.
  • Adoption of consolidated financial statements (ordinary) – passed.
  • Director retirement by rotation re-appointed (ordinary) – passed.
  • Arjun Lamba designated as Whole-time Director and Managing Director (special) – passed.

Director Changes

  • Director retiring by rotation re-appointed.
  • Arjun Lamba designated as Managing Director.

Audit & Related Party

  • No auditor changes disclosed.
  • No material related party transactions disclosed.
  • No other material approvals disclosed.

Dividend

  • No dividend proposed or declared.

Voting & Outcomes

  • All resolutions passed; near-unanimous support.
Filed 16:57View Source
24 Sept 20261 filing
AGM/EGMAGM

Religare Enterprises holds 42nd AGM via VC/OAVM; approves standalone and consolidated financials, and MD designation

AGM Details

  • AGM held Sept 24, 2026 at 03:00 p.m. IST via VC/OAVM.
  • Venue deemed at registered office under SS-II; proceedings conducted accordingly.
  • Meeting concluded at 3:53 p.m. IST.

Key Resolutions

  • Adoption of standalone financial statements for FY ending 31 March 2026.
  • Adoption of consolidated financial statements for FY ending 31 March 2026.
  • Appointment of Gurumurthy Ramanathan as director re-appointment (retiring by rotation).
  • Re-designation of Arjun Lamba as Managing Director; terms unchanged.

Voting Status

  • Results to be announced within two working days; final results subject to votes.
  • Resolutions deemed passed today, subject to receipt of requisite votes.

Dividend

  • No dividend proposed or declared at the AGM.

Director Changes

  • Gurumurthy Ramanathan retires by rotation; re-appointment offered.
  • Arjun Lamba redesignated as Managing Director; terms unchanged.

Auditors

  • No changes in statutory or other auditors disclosed.
Filed 17:42View Source
18 Sept 20262 filings
Company UpdateGeneral

Care Health Insurance issues Rs 100 crore unsecured subordinated NCDs; listing on NSE planned

CHIL debenture issue details

  • Issued 10,000 unsecured, subordinated NCDs of Rs 1 lakh each totaling Rs 100 crore.
  • Coupon rate fixed at 10% per annum; interest payable annually.
  • Tenor of 10 years; maturity on 18 September 2036.
  • Call option at end of year 5; issuer may redeem earlier.
  • Issuance on private placement basis; to be listed on NSE Debt Segment.
  • Listing on NSE Debt Segment effective 22 September 2026.
  • IRDAI regulatory approvals required for payment of interest in certain cases.
  • Debentures redeemable at par; no default interest unless IRDAI permit.
  • No security charged over assets; no special rights attached.
  • Religare notes CHIL as a material subsidiary.
Filed 18:18View Source
Company UpdateGeneral

Religare Enterprises establishes new Mumbai corporate office, operational from Sept 18, 2026

New corporate office

  • New corporate office established at Office No. 401, 4th Floor, Arena Space, Jogeshwari East, Mumbai.
  • Operations to commence from September 18, 2026.
Filed 18:13View Source
14 Sept 20261 filing
Company UpdateGeneral

Religare Enterprises appoints Rajender Malla as Non-Executive Chairperson through Sep 2026; continuation approved for Oct–Dec 2026.

Chairperson update

  • Rajender Mohan Malla, Independent Director, appointed Non-Executive Chairperson from 01-Jul-2026 to 30-Sep-2026.
  • Board approved continuation of Mr. Malla as Chairperson for 01-Oct-2026 to 31-Dec-2026 via circulation.
  • Chairmanship rotates among directors on a quarterly basis.
  • No financial terms disclosed in the update.
Filed 15:08View Source
3 Sept 20261 filing
Company UpdateNewspaper Publication

Newpaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 17:01View Source
2 Sept 20262 filings
Company UpdateGeneral

Religare Enterprises reports FY2025-26 BRSR: standalone filing, CSR not required due to losses, ESG governance updates

Key disclosures

  • BRSR filing for FY2025-26; standalone basis; forms part of Annual Report; available on REL website.
  • CSR not required due to three-year losses; Turnover 1,644.09 Lakhs; Net worth 2,46,615.24 Lakhs.
  • Board responsible for BR practices; CSR & ESG Committee established for ESG oversight.
  • Policies approved by Board; statutory policies available on REL website; employee policies on intranet.
  • Environmental: Non-renewable energy use 227.74 GJ electricity and 54.74 GJ fuel; total 282.48 GJ.
  • Emissions: Scope 1 4.01 tCO2e; Scope 2 44.92 tCO2e; total 48.93 tCO2e.
  • Water: third-party withdrawals 252.91 KL; total withdrawal 252.91 KL; consumption 141.63 KL.
  • Waste: total 0.30 MT; plastic 0.30 MT; no e-waste; disposal 0.30 MT.
  • Governance and compliance: No fines or penalties; Data Privacy policy; IT/Risk Committee oversight; no breaches.
  • Stakeholder engagement: Materiality risk assessment; ongoing stakeholder consultations; BR policies reviewed periodically.
Filed 22:14View Source
OthersReg. 34 (1) Annual Report

Religare Enterprises FY2025-26: Key highlights include strong income and profits, and ongoing capital actions

Religare Enterprises FY2025-26: Key highlights

  • Consolidated total income ₹8,493.84 Lakhs.
  • Consolidated PAT ₹7,316.38 Lakhs.
  • Consolidated EBITDA ₹170.14 Lakhs.
  • Consolidated Basic EPS ₹2.59.
  • CHIL GWP ₹11,417 crore.
  • RBI CAP removal completed; revival of lending operations underway.
  • Rights issue: ₹322.65 crore via 2,16,48,543 shares at ₹139.04.
  • Preferential issue: warrants up to ₹1,499.99 crore.
  • Demerger: financial services to Religare Finvest; RBI observations pending.
  • SEBI order: 31 Jul 2026; no adverse findings.
Filed 22:07View Source
Showing 10 of 99 filings